Patients with stage 1 or 2, hormone receptor (HR)-negative breast cancer had similar five-year rates of locoregional ...

Patients with stage 1 or 2, hormone receptor (HR)-negative breast cancer had similar five-year rates of locoregional ...

Tailoring breast cancer screening to a woman's individual cancer risk might work better than annual mammograms, researchers ...

Women with risk-based screening had about 30 cases of advanced cancer per 100,000 person-years, compared with 48 cases per ...

THE Ministry of Health recently hosted a comprehensive training closing session to mark the ending of a three-year International Atomic Energy Agency (IAEA) ...

Hologic, Inc. HOLX recently announced the latest clinical evidence showing the effectiveness of its Genius AI-based ...

Routine mammograms are a critical tool for breast cancer screening. However, they may also hold crucial, potentially untapped ...

"If I stick with my existing plan through MVP, I'd be paying $963 a month, so I made the choice to cancel," said former ACA ...

Danielle Fishel shared that following the completion of her breast cancer treatment, she's feeling healthy and positive ...

Routine mammograms are a critical tool for breast cancer screening. However, they may also hold crucial, potentially untapped ...

With this newly-developed AI model, it can be predicted with much greater precision that a woman will develop breast cancer in the next five years — on the basis of mammograms that are normal and show ...